1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baba, M; De Clercq, E; Inouye, N; Miyasaka, T; Sekiya, K; Shigeta, S; Takashima, H; Tanaka, H; Ubasawa, M; Walker, RT | 1 |
Chen, W; Li, Z; Liu, X; Wu, J; Zhan, P | 1 |
1 review(s) available for 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine and HIV Coinfection
Article | Year |
---|---|
The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO family.
Topics: Anti-HIV Agents; Crystallography, X-Ray; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thymine | 2012 |
1 other study(ies) available for 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine and HIV Coinfection
Article | Year |
---|---|
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
Topics: Animals; Antiviral Agents; Benzyl Compounds; HIV Infections; HIV-1; Humans; Lymphocytes; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship; Thymine | 1995 |